Singapore markets open in 2 hours 8 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,064.20 +45.81 (+0.91%) Dow
38,225.66 +322.37 (+0.85%) Nasdaq
15,840.96 +235.48 (+1.51%) Bitcoin USD
59,350.98 +1,408.67 (+2.43%) CMC Crypto 200
1,277.08 +6.34 (+0.50%)
GSK May 2024 32.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:15AM EDT. Market open.
| Previous close | 10.80 |
| Open | 11.20 |
| Bid | 10.80 |
| Ask | 12.50 |
| Strike | 32.00 |
| Expiry date | 2024-05-17 |
| Day's range | 11.20 - 11.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 47 |
Simply Wall St.GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
BenzingaGSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand for Arexvy and strong market growth for Shingrix in International and European markets. Shingrix sales reached 945 million Pounds, up 18% at constant currency, with Arexvy sales of 182 million Pounds. Specialty Medicine sales increased 17% to 2.5 billion poun
PA Media: MoneyGSK raises profit guidance as vaccine demand grows
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
© 2024 Yahoo. All rights reserved.